Ayala Pharmaceuticals Inc (fka ADXS)

[ignatiusrielly35]

I’ve always thought that this was exactly the plan. That Stendhal would use the Phase 3 data to piggyback Latin American approvals on the FDA application. I’m not sure I understand your question about separate trials.